M

Mankind Pharma Ltd
NSE:MANKIND

Watchlist Manager
Mankind Pharma Ltd
NSE:MANKIND
Watchlist
Price: 2 415.05 INR 7.58% Market Closed
Market Cap: 996.4B INR

Intrinsic Value

The intrinsic value of one MANKIND stock under the Base Case scenario is 1 686 INR. Compared to the current market price of 2 415.05 INR, Mankind Pharma Ltd is Overvalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MANKIND Intrinsic Value
1 686 INR
Overvaluation 30%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
Mankind Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MANKIND
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MANKIND cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Mankind Pharma Ltd
NSE:MANKIND
IN
Pharmaceuticals
Market Cap
967.6B INR
IPO
May 9, 2023
IN
Pharmaceuticals
Market Cap
967.6B INR
IPO
May 9, 2023
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MANKIND?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Mankind Pharma Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Mankind Pharma Ltd

Balance Sheet Decomposition
Mankind Pharma Ltd

Current Assets 85.4B
Cash & Short-Term Investments 47.6B
Receivables 12.8B
Other Current Assets 25.1B
Non-Current Assets 54.5B
Long-Term Investments 3.6B
PP&E 31.4B
Intangibles 16.4B
Other Non-Current Assets 3.1B
Efficiency

Free Cash Flow Analysis
Mankind Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mankind Pharma Ltd

Revenue
116.4B INR
Cost of Revenue
-33.6B INR
Gross Profit
82.8B INR
Operating Expenses
-58.4B INR
Operating Income
24.4B INR
Other Expenses
-4B INR
Net Income
20.4B INR
Fundamental Scores

MANKIND Profitability Score
Profitability Due Diligence

Mankind Pharma Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive 3-Year Average ROE
Positive Free Cash Flow
64/100
Profitability
Score

Mankind Pharma Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

MANKIND Solvency Score
Solvency Due Diligence

Mankind Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
97/100
Solvency
Score

Mankind Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MANKIND Price Targets Summary
Mankind Pharma Ltd

Wall Street analysts forecast MANKIND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MANKIND is 2 842.3 INR with a low forecast of 2 171.5 INR and a high forecast of 3 465 INR.

Lowest
Price Target
2 171.5 INR
10% Downside
Average
Price Target
2 842.3 INR
18% Upside
Highest
Price Target
3 465 INR
43% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Mankind Pharma Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for MANKIND is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MANKIND Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MANKIND stock?

The intrinsic value of one MANKIND stock under the Base Case scenario is 1 686 INR.

Is MANKIND stock undervalued or overvalued?

Compared to the current market price of 2 415.05 INR, Mankind Pharma Ltd is Overvalued by 30%.

Back to Top